BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20818158)

  • 1. IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.
    Liu Y; Fuchs J; Li C; Lin J
    Cell Cycle; 2010 Sep; 9(17):3423-7. PubMed ID: 20818158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y; Liu A; Li H; Li C; Lin J
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M; Li C; Lin J; Javle M
    Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
    Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
    Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y; Liu A; Xu Z; Yu W; Wang H; Li C; Lin J
    Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
    Liu Y; Li PK; Li C; Lin J
    J Biol Chem; 2010 Aug; 285(35):27429-27439. PubMed ID: 20562100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.
    Lin L; Deangelis S; Foust E; Fuchs J; Li C; Li PK; Schwartz EB; Lesinski GB; Benson D; Lü J; Hoyt D; Lin J
    Mol Cancer; 2010 Aug; 9():217. PubMed ID: 20712901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.
    Liu A; Liu Y; Li PK; Li C; Lin J
    Anticancer Res; 2011 Jun; 31(6):2029-35. PubMed ID: 21737619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.
    Bill MA; Fuchs JR; Li C; Yui J; Bakan C; Benson DM; Schwartz EB; Abdelhamid D; Lin J; Hoyt DG; Fossey SL; Young GS; Carson WE; Li PK; Lesinski GB
    Mol Cancer; 2010 Jun; 9():165. PubMed ID: 20576164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Hu Z; Luo D; Wang D; Ma L; Zhao Y; Li L
    Cell Physiol Biochem; 2017; 43(6):2379-2390. PubMed ID: 29073625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.
    Bill MA; Nicholas C; Mace TA; Etter JP; Li C; Schwartz EB; Fuchs JR; Young GS; Lin L; Lin J; He L; Phelps M; Li PK; Lesinski GB
    PLoS One; 2012; 7(8):e40724. PubMed ID: 22899991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
    Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog.
    Abuzeid WM; Davis S; Tang AL; Saunders L; Brenner JC; Lin J; Fuchs JR; Light E; Bradford CR; Prince ME; Carey TE
    Arch Otolaryngol Head Neck Surg; 2011 May; 137(5):499-507. PubMed ID: 21576562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
    Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
    BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma.
    Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z
    J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.